Screening and Assessment of Coronary Heart Disease in HIV-Infected Patients
- 8 July 2008
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 118 (2), e41-7
- https://doi.org/10.1161/circulationaha.107.189626
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Assessing inflammatory status in cardiovascular diseaseHeart, 2007
- N-Terminal Fragment of the Prohormone Brain-Type Natriuretic Peptide (NT-proBNP), Cardiovascular Events, and Mortality in Patients With Stable Coronary Heart DiseasePublished by American Medical Association (AMA) ,2007
- Carotid Intimal Medial Thickness in Human Immunodeficiency Virus-Infected Women: Effects of Protease Inhibitor Use, Cardiac Risk Factors, and the Metabolic SyndromeJournal of Clinical Endocrinology & Metabolism, 2006
- Linking inflammation and atherogenesis: Soluble markers identified for the detection of risk factors and for early risk assessmentClinica Chimica Acta; International Journal of Clinical Chemistry, 2006
- Subclinical Carotid Atherosclerosis in HIV-Infected PatientsStroke, 2006
- Primary Care Guidelines for the Management of Persons Infected with Human Immunodeficiency Virus: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2004
- Effects of pravastatin on lipoproteins and endothelial function in patients receiving human immunodeficiency virus protease inhibitorsAmerican Heart Journal, 2004
- HIV infection, HAART, and endothelial adhesion molecules: current perspectivesThe Lancet Infectious Diseases, 2004
- Increased VLDL-apoB and IDL-apoB production rates in nonlipodystrophic HIV-infected patients on a protease inhibitor-containing regimenJournal of Lipid Research, 2003
- Asymptomatic Atherosclerosis in HIV-positive Patients: A Case-control Ultrasound StudyAnnals of Medicine, 1995